Toxicology presentations are pattern-recognition problems. Not because the patterns are simple — they are not — but because the clinical syndrome produced by a toxic exposure is predictable enough that a clinician who knows the toxidrome can work backward from the presentation to the agent class, and from the agent class to the correct intervention, without ever knowing exactly what was taken.

This is what the CEN tests. This is also what saves the patient whose family says they found them unresponsive and doesn’t know what happened.

The five classic toxidromes.

A toxidrome is a constellation of findings produced by a specific pharmacological mechanism. Memorizing lists of agents is less useful than understanding the mechanism, because the mechanism explains the findings and the findings point to the intervention.

Cholinergic toxidrome (organophosphates, nerve agents, some mushrooms) results from excess acetylcholine accumulation at muscarinic and nicotinic receptors. The muscarinic findings are summarized by SLUDGE: Salivation, Lacrimation, Urination, Defecation, GI distress, Emesis — plus bradycardia, bronchospasm, bronchorrhea, and miosis. The nicotinic findings include tachycardia, hypertension, muscle fasciculations, and weakness progressing to paralysis.

The clinical priority: the most immediately lethal finding is bronchorrhea combined with bronchospasm — a patient drowning in their own secretions. Airway is the first priority, followed by atropine (blocks muscarinic effects; dose to dry secretions, not to heart rate) and pralidoxime (reactivates acetylcholinesterase if given early, before the enzyme “ages”). The DUMBELS mnemonic (Defecation, Urination, Miosis, Bradycardia, Emesis, Lacrimation, Salivation) captures the same findings in a different order — use whichever is faster for you.

Anticholinergic toxidrome (diphenhydramine, tricyclic antidepressants, atropine, jimsonweed) results from blockade of acetylcholine at muscarinic receptors. The classic teaching mnemonic: hot as a hare, blind as a bat, dry as a bone, red as a beet, mad as a hatter. Clinically: hyperthermia, mydriasis, urinary retention, dry flushed skin, tachycardia, and delirium or agitation.

The clinical priority: hyperthermia in anticholinergic toxicity can be rapidly fatal. The inability to sweat means the patient cannot regulate temperature. Aggressive cooling is a priority alongside supportive care. Physostigmine (a reversible acetylcholinesterase inhibitor) can reverse peripheral and central anticholinergic effects but carries its own risks — use is selective and requires physician direction. Benzodiazepines for agitation. Avoid physostigmine in TCA overdose due to the seizure and cardiac conduction risk.

Sympathomimetic toxidrome (cocaine, amphetamines, MDMA, ephedrine) results from excess catecholamine activity. Tachycardia, hypertension, hyperthermia, diaphoresis, mydriasis, agitation. This looks similar to anticholinergic toxidrome but differs in one key way: sympathomimetic patients are diaphoretic (sweating from adrenergic stimulation); anticholinergic patients are dry.

The clinical priority: cardiovascular and thermoregulatory. Cocaine-associated chest pain requires a different approach than typical ACS — beta-blockers are contraindicated in pure cocaine toxicity because of unopposed alpha-adrenergic vasoconstriction. Benzodiazepines are first-line for agitation and can reduce heart rate and blood pressure through CNS sedation. Hyperthermia requires aggressive external cooling.

Opioid toxidrome (heroin, fentanyl, oxycodone, methadone) results from mu-opioid receptor agonism. The classic triad: miosis, CNS depression, respiratory depression. The findings are dose-dependent — early opioid intoxication may produce only sedation and miosis; life-threatening toxicity adds respiratory failure.

The clinical priority: respiratory depression is the killer. Naloxone (0.4–2 mg IV/IM/IN) is the antidote — titrate to adequate respiratory effort, not to full consciousness. An awake, agitated patient who immediately goes into opioid withdrawal is harder to manage and more likely to leave. With synthetic opioids (fentanyl, carfentanil), higher and repeat doses of naloxone may be required, and the duration of naloxone effect (30–90 minutes) may be shorter than the duration of the opioid — redosing or infusion is often necessary.

Sedative-hypnotic toxidrome (benzodiazepines, barbiturates, alcohol, GHB) results from CNS depression via GABA enhancement. CNS depression, respiratory depression, slurred speech, ataxia, amnesia. Unlike opioids, miosis is not reliable and the pupillary exam is less useful. Unlike anticholinergics, patients are not agitated.

The clinical priority: supportive care and airway protection. Flumazenil reverses benzodiazepine effect but is not routinely used — it can precipitate seizures in patients with chronic benzodiazepine use or mixed ingestions with proconvulsant agents. In most benzodiazepine overdose, airway management and observation are preferred over reversal.

The mixed ingestion problem.

Real toxicology patients frequently do not present with clean single-agent toxidromes. Alcohol is involved in a significant portion of ED overdose presentations and modifies the picture. Polypharmacy overdoses blend findings from multiple mechanisms. The approach to an unclear presentation is not to cycle through mnemonics until something fits — it is to identify the dominant physiologic derangement (vital sign pattern, level of consciousness, pupillary response, presence or absence of diaphoresis) and reason toward the most dangerous plausible agent.

In mixed presentations, prioritize the most immediately lethal component. A patient with a blended opioid and stimulant picture needs airway assessment first. A patient with unclear ingestion and QRS prolongation needs sodium bicarbonate consideration regardless of the specific agent, because the intervention targets the electrophysiologic derangement, not the agent class.

The exam relevance.

CEN toxicology questions test whether candidates can identify the toxidrome, select the appropriate first intervention, and recognize the key clinical priority within each syndrome. They test reasoning to the mechanism, not agent recall. A question about an unknown ingestion with dry flushed skin, mydriasis, tachycardia, and urinary retention is testing whether you recognize the anticholinergic picture and know that cooling and sedation precede reversal consideration — not whether you can name every anticholinergic agent.

That is the standard this content is built to. The mechanism explains the finding. The finding points to the intervention. The intervention is traceable to the physiology.